ALVIO — Valerio Therapeutics SA Balance Sheet
0.000.00%
- €10.01m
- €19.19m
- €1.80m
Annual balance sheet for Valerio Therapeutics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5.71 | 14.5 | 17.9 | 14.6 | 6.82 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.32 | 8.25 | 10.8 | 5.71 | 5.01 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 11.3 | 23.2 | 30.1 | 20.6 | 13 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.83 | 2.56 | 2.24 | 1.89 | 1.53 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 37.6 | 46.5 | 53.1 | 43.1 | 35.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.2 | 6.05 | 7.06 | 7.15 | 11.1 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 20.4 | 17.5 | 20.1 | 20.8 | 20.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 17.2 | 29 | 32.9 | 22.3 | 14.8 |
Total Liabilities & Shareholders' Equity | 37.6 | 46.5 | 53.1 | 43.1 | 35.3 |
Total Common Shares Outstanding |